News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,670 Results
Type
Article (67128)
Company Profile (361)
Press Release (661181)
Multimedia
Podcasts (105)
Webinars (14)
Section
Business (205079)
Career Advice (2646)
Deals (34055)
Drug Delivery (105)
Drug Development (84304)
Employer Resources (159)
FDA (16570)
Job Trends (14983)
News (347374)
Policy (32231)
Tag
2024 BioCapital Digital (13)
2024 BioForest Digital (10)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (12)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (7)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (14)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2930)
Academic (2)
Accelerated approval (5)
Adcomms (18)
Allergies (90)
Alliances (52948)
ALS (98)
Alzheimer's disease (1479)
Antibody-drug conjugate (ADC) (150)
Approvals (16564)
Artificial intelligence (284)
Autoimmune disease (26)
Automation (16)
Bankruptcy (318)
Best Places to Work (11749)
BIOSECURE Act (21)
Biosimilars (97)
Biotechnology (249)
Bladder cancer (81)
Brain cancer (31)
Breast cancer (296)
Cancer (2376)
Cardiovascular disease (190)
Career advice (2206)
Career pathing (31)
CAR-T (161)
Cell therapy (467)
Cervical cancer (21)
Clinical research (67850)
Collaboration (901)
Compensation (511)
Complete response letters (25)
COVID-19 (2813)
CRISPR (46)
C-suite (254)
Cystic fibrosis (102)
Data (2233)
Decentralized trials (2)
Denatured (40)
Depression (52)
Diabetes (277)
Diagnostics (6560)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (131)
Drug pricing (98)
Drug shortages (24)
Duchenne muscular dystrophy (95)
Earnings (81507)
Editorial (39)
Employer branding (20)
Employer resources (139)
Events (113303)
Executive appointments (754)
FDA (17849)
Featured Employer (60)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (794)
Gene editing (115)
Generative AI (29)
Gene therapy (334)
GLP-1 (778)
Government (4488)
Grass and pollen (5)
Guidances (53)
Healthcare (19241)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (135)
Indications (30)
Infectious disease (2966)
Inflammatory bowel disease (147)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (100)
Interviews (478)
IPO (16174)
IRA (45)
Job creations (3700)
Job search strategy (1877)
Kidney cancer (11)
Labor market (30)
Layoffs (491)
Leadership (21)
Legal (7208)
Liver cancer (80)
Lung cancer (338)
Lymphoma (151)
Machine learning (6)
Management (54)
Manufacturing (322)
MASH (72)
Medical device (13607)
Medtech (13611)
Mergers & acquisitions (18467)
Metabolic disorders (727)
Multiple sclerosis (84)
NASH (20)
Neurodegenerative disease (107)
Neuropsychiatric disorders (31)
Neuroscience (2063)
NextGen: Class of 2025 (6688)
Non-profit (4692)
Northern California (2666)
Now hiring (29)
Obesity (383)
Opinion (258)
Ovarian cancer (77)
Pain (92)
Pancreatic cancer (86)
Parkinson's disease (158)
Partnered (23)
Patents (240)
Patient recruitment (111)
Peanut (49)
People (59119)
Pharmaceutical (84)
Pharmacy benefit managers (13)
Phase I (21261)
Phase II (29770)
Phase III (22187)
Pipeline (1209)
Policy (139)
Postmarket research (2858)
Preclinical (9541)
Press Release (72)
Prostate cancer (113)
Psychedelics (37)
Radiopharmaceuticals (268)
Rare diseases (402)
Real estate (6171)
Recruiting (64)
Regulatory (22713)
Reports (35)
Research institute (2624)
Resumes & cover letters (412)
Rett syndrome (5)
RNA editing (5)
RSV (46)
Schizophrenia (78)
Series A (140)
Series B (90)
Service/supplier (16)
Sickle cell disease (55)
Southern California (2315)
Special edition (16)
Spinal muscular atrophy (159)
Sponsored (33)
Startups (3842)
State (1)
Stomach cancer (15)
Supply chain (70)
Tariffs (30)
The Weekly (63)
United States (23479)
Vaccines (773)
Venture capitalists (39)
Weight loss (263)
Women's health (36)
Worklife (18)
Date
Today (223)
Last 7 days (936)
Last 30 days (2779)
Last 365 days (34083)
2025 (10909)
2024 (36478)
2023 (41302)
2022 (52622)
2021 (57036)
2020 (55219)
2019 (47669)
2018 (36069)
2017 (34211)
2016 (34030)
2015 (40211)
2014 (33448)
2013 (29521)
2012 (30296)
2011 (30507)
2010 (28798)
Location
Africa (977)
Alabama (60)
Alaska (6)
Arizona (200)
Arkansas (14)
Asia (43636)
Australia (7624)
California (6163)
Canada (2002)
China (548)
Colorado (270)
Connecticut (288)
Delaware (151)
Europe (99933)
Florida (917)
Georgia (202)
Idaho (51)
Illinois (540)
India (28)
Indiana (302)
Iowa (10)
Japan (163)
Kansas (109)
Kentucky (23)
Louisiana (12)
Maine (69)
Maryland (926)
Massachusetts (4697)
Michigan (233)
Minnesota (401)
Mississippi (1)
Missouri (83)
Montana (31)
Nebraska (25)
Nevada (61)
New Hampshire (62)
New Jersey (1740)
New Mexico (31)
New York (1756)
North Carolina (1047)
North Dakota (9)
Northern California (2666)
Ohio (213)
Oklahoma (15)
Oregon (37)
Pennsylvania (1357)
Puerto Rico (10)
Rhode Island (30)
South America (1272)
South Carolina (23)
South Dakota (1)
Southern California (2315)
Tennessee (99)
Texas (912)
Utah (185)
Virginia (158)
Washington D.C. (63)
Washington State (579)
West Virginia (3)
Wisconsin (64)
728,670 Results for "biomedical advanced research and development authority barda".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium
November 5, 2024
·
6 min read
Decentralized trials
Walgreens, BARDA Team in $100M Partnership to Boost Decentralized Clinical Trials
The retail pharmacy giant and the Biomedical Advanced Research and Development Authority hope to make decentralized clinical trials more accessible and representative of the U.S. population.
August 20, 2024
·
2 min read
·
Tristan Manalac
Biotech Beach
Qpex Biopharma, a Shionogi Group Company, Receives an Additional $10M Award by BARDA as Part of Qpex’s Partnership to Advance its Portfolio of Antibiotics Addressing Drug-Resistant Infections
Qpex Biopharma, Inc. today announced the exercise of a $10 million option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services, to support the advancement of the company’s antibiotic clinical development program.
May 30, 2024
·
5 min read
Press Releases
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
January 29, 2025
·
8 min read
Press Releases
Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
January 14, 2025
·
4 min read
BARDA Selects Edesa Biotech’s Drug for U.S. Funded Platform Trial in General ARDS
Edesa Biotech, Inc. announced today that its first-in-class drug candidate has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, for evaluation in a U.S. government-funded clinical study.
June 24, 2024
·
7 min read
Press Releases
UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
January 14, 2025
·
4 min read
Vaccines
Moderna to Produce Bird Flu Vaccine Under $176M BARDA Project Award
Moderna on Tuesday announced it has been awarded $176 million by a consortium funded by the Biomedical Advanced Research and Development Authority to develop an mRNA-based vaccine to counter H5N1 avian influenza.
July 2, 2024
·
2 min read
·
Tyler Patchen
Drug Development
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)
InflaRx N.V. (Nasdaq: IFRX) announced today that GOHIBIC (vilobelimab) has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, as one of three investigational therapies to be assessed in a Phase 2 clinical platform study exploring potential new options for the treatment of acute respiratory distress syndrome (ARDS).
June 24, 2024
·
12 min read
Enhancing National Preparedness: Rafa Laboratories Partners with BARDA to Advance the Development of a new design for Rafa’s Pediatric Atropine Autoinjectors
Rafa Laboratories, LTD., a leading manufacturer of Emergency Medical Solutions, and the Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services, aim to enhance the national preparedness for nerve agent emergencies by developing a new design for Rafa’s pediatric atropine autoinjectors.
March 20, 2024
·
3 min read
1 of 72,867
Next
